Cost-effectiveness comparison of three methods for differential cell count in induced sputum Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002
The relationship between total and differential cell counts in induced sputum Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002
How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA) Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020
The need of analysing induced sputum absolute cell counts in addition to cell percentages in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004
Establishing normal ranges for induced sputum cell counts in Singapore Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015
The search for the “healthy” blood eosinophil count Source: Eur Respir J, 55 (5) 2000473; 10.1183/13993003.00473-2020 Year: 2020
Lack of correlation between BAL and induced sputum cell counts Source: Eur Respir J 2001; 18: Suppl. 33, 508s Year: 2001
Improving automated cell recognition of sputum and BAL cells for Chipcytometry analysis Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020
The reproducibility of COPD blood eosinophil counts Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018 Year: 2018
The effect of time elapsed since expectoration on sputum eosinophil differential cell counts Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019
Sputum cell counts in bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 484s Year: 2005
Reproducibility of COPD blood eosinophil counts Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018
Clinical significance of blood neutrophil differential count in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019
Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005
Peripheral eosinophil count as a biomarker for the management of COPD: not there yet Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017 Year: 2017
Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial Source: Eur Respir J, 58 (3) 2004522; 10.1183/13993003.04522-2020 Year: 2021